EyeAI: AI-Assisted Ocular Disease Detection for Equitable Healthcare Access

• URL: http://arxiv.org/abs/2507.20346v1
• Date: Sun, 27 Jul 2025 16:29:41 GMT
• Title: EyeAI: AI-Assisted Ocular Disease Detection for Equitable Healthcare Access
• Authors: Shiv Garg, Ginny Berkemeier,
• Abstract summary: Ocular disease affects billions of individuals unevenly worldwide.<n>We present EyeAI, a system designed to provide artificial intelligence-assisted detection of ocular diseases.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Ocular disease affects billions of individuals unevenly worldwide. It continues to increase in prevalence with trends of growing populations of diabetic people, increasing life expectancies, decreasing ophthalmologist availability, and rising costs of care. We present EyeAI, a system designed to provide artificial intelligence-assisted detection of ocular diseases, thereby enhancing global health. EyeAI utilizes a convolutional neural network model trained on 1,920 retinal fundus images to automatically diagnose the presence of ocular disease based on a retinal fundus image input through a publicly accessible web-based application. EyeAI performs a binary classification to determine the presence of any of 45 distinct ocular diseases, including diabetic retinopathy, media haze, and optic disc cupping, with an accuracy of 80%, an AUROC of 0.698, and an F1-score of 0.8876. EyeAI addresses barriers to traditional ophthalmologic care by facilitating low-cost, remote, and real-time diagnoses, particularly for equitable access to care in underserved areas and for supporting physicians through a secondary diagnostic opinion. Results demonstrate the potential of EyeAI as a scalable, efficient, and accessible diagnostic tool. Future work will focus on expanding the training dataset to enhance the accuracy of the model further and improve its diagnostic capabilities.

Related papers

• A Clinician-Friendly Platform for Ophthalmic Image Analysis Without Technical Barriers [51.45596445363302]
  GlobeReady is a clinician-friendly AI platform that enables fundus disease diagnosis without retraining, fine-tuning, or the needs for technical expertise.<n>We demonstrate high accuracy across imaging modalities: 93.9-98.5% for 11 fundus diseases using color fundus photographs (CPFs) and 87.2-92.7% for 15 fundus diseases using optic coherence tomography ( OCT) scans.<n>By leveraging training-free local feature augmentation, GlobeReady platform effectively mitigates domain shifts across centers and populations.
  arXiv  Detail & Related papers  (2025-04-22T14:17:22Z)
• EyecareGPT: Boosting Comprehensive Ophthalmology Understanding with Tailored Dataset, Benchmark and Model [51.66031028717933]
  Medical Large Vision-Language Models (Med-LVLMs) demonstrate significant potential in healthcare.<n>Currently, intelligent ophthalmic diagnosis faces three major challenges: (i) Data; (ii) Benchmark; and (iii) Model.<n>We propose the Eyecare Kit, which tackles the aforementioned three key challenges with the tailored dataset, benchmark and model.
  arXiv  Detail & Related papers  (2025-04-18T12:09:15Z)
• Federated Learning for Diabetic Retinopathy Diagnosis: Enhancing Accuracy and Generalizability in Under-Resourced Regions [0.3277163122167433]
  Diabetic retinopathy is the leading cause of vision loss in working-age adults worldwide, yet under-resourced regions lack ophthalmologists. Current state-of-the-art deep learning systems struggle at these institutions due to limited generalizability. This paper explores a novel federated learning system for diabetic retinopathy diagnosis with the EfficientNetB0 architecture.
  arXiv  Detail & Related papers  (2024-10-30T23:56:56Z)
• Enhancing Community Vision Screening -- AI Driven Retinal Photography for Early Disease Detection and Patient Trust [17.849524259801765]
  Community vision screening plays a crucial role in identifying individuals with vision loss and preventing avoidable blindness. There is a pressing need for a simple and efficient process to screen and refer individuals with eye disease-related vision loss to tertiary eye care centers for further care. This paper introduces the Enhancing Community Vision Screening (ECVS) solution based on simple, non-invasive retinal photography for the detection of pathology-based visual impairment.
  arXiv  Detail & Related papers  (2024-10-27T02:31:19Z)
• A Survey of Artificial Intelligence in Gait-Based Neurodegenerative Disease Diagnosis [51.07114445705692]
  neurodegenerative diseases (NDs) traditionally require extensive healthcare resources and human effort for medical diagnosis and monitoring.<n>As a crucial disease-related motor symptom, human gait can be exploited to characterize different NDs.<n>The current advances in artificial intelligence (AI) models enable automatic gait analysis for NDs identification and classification.
  arXiv  Detail & Related papers  (2024-05-21T06:44:40Z)
• Eye-tracking in Mixed Reality for Diagnosis of Neurodegenerative Diseases [0.2686968510141288]
  Parkinson's disease ranks as the second most prevalent neurodegenerative disorder globally. This research aims to develop a system leveraging Mixed Reality capabilities for tracking and assessing eye movements.
  arXiv  Detail & Related papers  (2024-04-19T16:34:15Z)
• Algorithm-based diagnostic application for diabetic retinopathy detection [0.0]
  Diabetic retinopathy is a growing health problem worldwide and is a leading cause of visual impairment and blindness. Recent research in the field of diabetic retinopathy diagnosis is using advanced technologies, such as analysis of images obtained by ophthalmoscopy. This paper describes an automatic DR diagnosis method that includes processing and analysis of ophthalmoscopic images of the eye.
  arXiv  Detail & Related papers  (2023-12-01T12:09:06Z)
• Multi-Scale Hybrid Vision Transformer for Learning Gastric Histology: AI-Based Decision Support System for Gastric Cancer Treatment [50.89811515036067]
  Gastric endoscopic screening is an effective way to decide appropriate gastric cancer (GC) treatment at an early stage, reducing GC-associated mortality rate. We propose a practical AI system that enables five subclassifications of GC pathology, which can be directly matched to general GC treatment guidance.
  arXiv  Detail & Related papers  (2022-02-17T08:33:52Z)
• Assessing glaucoma in retinal fundus photographs using Deep Feature Consistent Variational Autoencoders [63.391402501241195]
  glaucoma is challenging to detect since it remains asymptomatic until the symptoms are severe. Early identification of glaucoma is generally made based on functional, structural, and clinical assessments. Deep learning methods have partially solved this dilemma by bypassing the marker identification stage and analyzing high-level information directly to classify the data.
  arXiv  Detail & Related papers  (2021-10-04T16:06:49Z)
• Efficient Screening of Diseased Eyes based on Fundus Autofluorescence Images using Support Vector Machine [0.12189422792863448]
  A variety of vision ailments are associated with geographic atrophy (GA) in the foveal region of the eye. In current clinical practice, the ophthalmologist manually detects potential presence of such GA based on fundus autofluorescence (FAF) images. We propose a screening step, where healthy and diseased eyes are algorithmically differentiated with limited input from only optometrists.
  arXiv  Detail & Related papers  (2021-04-17T11:54:34Z)
• An Interpretable Multiple-Instance Approach for the Detection of referable Diabetic Retinopathy from Fundus Images [72.94446225783697]
  We propose a machine learning system for the detection of referable Diabetic Retinopathy in fundus images. By extracting local information from image patches and combining it efficiently through an attention mechanism, our system is able to achieve high classification accuracy. We evaluate our approach on publicly available retinal image datasets, in which it exhibits near state-of-the-art performance.
  arXiv  Detail & Related papers  (2021-03-02T13:14:15Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.